0001022079-20-000002.txt : 20200103 0001022079-20-000002.hdr.sgml : 20200103 20200103163920 ACCESSION NUMBER: 0001022079-20-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200102 FILED AS OF DATE: 20200103 DATE AS OF CHANGE: 20200103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Davis J. E. CENTRAL INDEX KEY: 0001599837 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 20506152 MAIL ADDRESS: STREET 1: C/O QUEST DIAGNOSTICS STREET 2: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 4 1 wf-form4_157808754276203.xml FORM 4 X0306 4 2020-01-02 0 0001022079 QUEST DIAGNOSTICS INC DGX 0001599837 Davis J. E. 500 PLAZA DRIVE SECAUCUS NJ 07094 0 1 0 0 EVP, General Diagnostics Common Stock 2020-01-02 4 M 0 65681 71.17 A 102215 D Common Stock 2020-01-02 4 M 0 77865 66.51 A 180080 D Common Stock 2020-01-02 4 S 0 58258 105.458 D 121822 D Common Stock 2020-01-02 4 S 0 7423 106.513 D 114399 D Common Stock 2020-01-02 4 S 0 69003 105.452 D 45396 D Common Stock 2020-01-02 4 S 0 8853 106.511 D 36543 D Non-Qualifed Stock Option (right to buy) 71.17 2020-01-02 4 M 0 65681 71.17 D 2025-02-23 Common Stock 65681.0 0 D Non-Qualifed Stock Option (right to buy) 66.51 2020-01-02 4 M 0 77865 66.51 D 2026-02-25 Common Stock 77865.0 0 D This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. This transaction was executed in multiple trades at prices ranging from $105.00 to $105.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $106.00 to $106.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $105.00 to $106.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $106.01 to $106.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The options vested in three equal annual installments beginning with the first on February 23, 2016, the second on February 23, 2017 and the final on February 23, 2018. The options vested in three equal annual installments beginning with the first on February 25, 2017, the second on February 25, 2018 and the final on February 25, 2019. /s/ William J. O'Shaughnessy, Jr., attorney-in-fact for James E. Davis 2020-01-03